Nisa Investment Advisors LLC Lowers Stake in Global Medical REIT Inc. (NYSE:GMRE)

Nisa Investment Advisors LLC cut its position in Global Medical REIT Inc. (NYSE:GMRE) by 15.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,362 shares of the company’s stock after selling 5,030 shares during the period. Nisa Investment Advisors LLC’s holdings in Global Medical REIT were worth $217,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its stake in Global Medical REIT by 54.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock worth $2,298,000 after buying an additional 81,596 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Global Medical REIT by 228.9% in the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock worth $1,073,000 after acquiring an additional 80,030 shares during the period. AQR Capital Management LLC grew its position in shares of Global Medical REIT by 71.1% during the second quarter. AQR Capital Management LLC now owns 188,931 shares of the company’s stock worth $1,715,000 after purchasing an additional 78,528 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Global Medical REIT by 158.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company’s stock valued at $1,195,000 after purchasing an additional 73,965 shares during the period. Finally, Barclays PLC lifted its holdings in Global Medical REIT by 87.1% in the 3rd quarter. Barclays PLC now owns 154,051 shares of the company’s stock worth $1,527,000 after purchasing an additional 71,704 shares in the last quarter. 57.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank began coverage on shares of Global Medical REIT in a report on Friday, October 18th. They set a “buy” rating and a $11.75 price objective for the company.

Global Medical REIT Stock Down 2.1 %

GMRE opened at $7.85 on Thursday. Global Medical REIT Inc. has a 52 week low of $7.33 and a 52 week high of $10.46. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The firm has a 50-day simple moving average of $8.16 and a two-hundred day simple moving average of $8.95. The company has a market capitalization of $524.07 million, a PE ratio of -392.05, a price-to-earnings-growth ratio of 1.34 and a beta of 1.23.

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.18). Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The firm had revenue of $34.26 million for the quarter, compared to the consensus estimate of $34.88 million. During the same period in the previous year, the company posted $0.23 earnings per share. Analysts forecast that Global Medical REIT Inc. will post 0.81 earnings per share for the current fiscal year.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Shareholders of record on Friday, December 20th were paid a dividend of $0.21 per share. The ex-dividend date was Friday, December 20th. This represents a $0.84 annualized dividend and a yield of 10.71%. Global Medical REIT’s payout ratio is currently -4,200.00%.

Global Medical REIT Company Profile

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.